|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
1,154,000 |
Market
Cap: |
N/A |
Last
Volume: |
34,784 |
Avg
Vol: |
14,861 |
52
Week Range: |
$0.22 - $0.22 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Pressure BioSciences is engaged in the development and sale of pressure-based platform solutions for the life sciences industry. Co.'s solutions are based on the properties of both constant and alternating pressure cycling technology, or PCT hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. Co.'s primary focus has been in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pollack Kevin |
Director |
|
2018-09-18 |
4 |
A |
$4.01 |
$1,267 |
D/D |
316 |
16,707 |
|
- |
|
Schumacher Richard T |
President, CEO |
|
2018-03-27 |
4 |
A |
$3.32 |
$554 |
D/D |
167 |
35,384 |
|
- |
|
Urdea Michael S |
Director |
|
2018-03-27 |
4 |
A |
$3.32 |
$1,278 |
D/D |
385 |
13,055 |
|
- |
|
Peterson Jeffrey N |
Director |
|
2018-03-27 |
4 |
A |
$3.32 |
$1,165 |
D/D |
351 |
13,866 |
|
- |
|
Mangiardi Vito J |
Director |
|
2018-03-27 |
4 |
A |
$3.32 |
$279 |
D/D |
84 |
11,726 |
|
- |
|
Pollack Kevin |
Director |
|
2018-03-27 |
4 |
A |
$3.32 |
$1,295 |
D/D |
390 |
16,391 |
|
- |
|
Schumacher Richard T |
President, CEO |
|
2018-03-14 |
4 |
A |
$4.19 |
$557 |
D/D |
133 |
35,217 |
|
- |
|
Mangiardi Vito J |
Director |
|
2018-03-14 |
4 |
A |
$4.19 |
$281 |
D/D |
67 |
11,642 |
|
- |
|
Peterson Jeffrey N |
Director |
|
2018-03-14 |
4 |
A |
$4.19 |
$1,165 |
D/D |
278 |
13,515 |
|
- |
|
Urdea Michael S |
Director |
|
2018-03-14 |
4 |
A |
$4.19 |
$1,278 |
D/D |
305 |
12,670 |
|
- |
|
Pollack Kevin |
Director |
|
2018-03-14 |
4 |
A |
$4.19 |
$1,295 |
D/D |
309 |
16,001 |
|
- |
|
Schumacher Richard T |
President, CEO |
|
2017-11-22 |
4 |
A |
$7.66 |
$552 |
D/D |
72 |
35,084 |
|
- |
|
Peterson Jeffrey N |
Director |
|
2017-11-22 |
4 |
A |
$7.66 |
$1,157 |
D/D |
151 |
13,237 |
|
- |
|
Urdea Michael S |
Director |
|
2017-11-22 |
4 |
A |
$7.66 |
$1,264 |
D/D |
165 |
12,365 |
|
- |
|
Mangiardi Vito J |
Director |
|
2017-11-22 |
4 |
A |
$7.66 |
$276 |
D/D |
36 |
11,575 |
|
- |
|
Pollack Kevin |
Director |
|
2017-11-22 |
4 |
A |
$7.66 |
$1,386 |
D/D |
181 |
15,692 |
|
- |
|
Damasio Joseph Luis Jr |
VP of FINANCE and CFOOfficer |
|
2017-04-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
210 |
|
- |
|
Mangiardi Vito J |
Director |
|
2014-12-22 |
4 |
A |
$0.25 |
$5,000 |
D/D |
20,000 |
20,000 |
|
- |
|
Schumacher Richard T |
CEO |
|
2014-12-22 |
4 |
A |
$0.25 |
$3,153 |
D/D |
12,610 |
703,854 |
|
- |
|
Peterson Jeffrey N |
Director |
|
2014-12-22 |
4 |
A |
$0.25 |
$5,750 |
D/D |
23,000 |
25,976 |
|
- |
|
Pollack Kevin |
Director |
|
2014-12-22 |
4 |
A |
$0.25 |
$10,000 |
D/D |
40,000 |
57,500 |
|
- |
|
Lazarev Alexander V |
VP of Research and Development |
|
2014-12-22 |
4 |
A |
$0.25 |
$250 |
D/D |
1,000 |
7,351 |
|
- |
|
Urdea Michael S |
Director |
|
2014-12-22 |
4 |
A |
$0.25 |
$14,250 |
D/D |
57,000 |
107,000 |
|
- |
|
Lawrence Nathan |
VP of Marketing and Sales |
|
2014-12-22 |
4 |
A |
$0.25 |
$1,555 |
D/D |
6,220 |
20,618 |
|
- |
|
Schumacher Richard T |
CEO |
|
2014-12-22 |
4 |
A |
$0.25 |
$5,435 |
D/D |
21,740 |
691,244 |
|
- |
|
153 Records found
|
|
Page 6 of 7 |
|
|